John W. Loughney

The poly(ADP-ribose) polymerase inhibitor niraparib (MK4827) in BRCA mutation carriers and patients with sporadic cancer: a phase 1 dose-escalation trial

Shahneen Sandhu, William R. Schelman, George Wilding et al. · The Lancet Oncology · 2013 · 551 citations

Sporadic Cancer, Medicine, Brca Mutation Carriers +7

Neutralization of Diverse Human Cytomegalovirus Strains Conferred by Antibodies Targeting Viral gH/gL/pUL128-131 Pentameric Complex

Sha Ha, Fengsheng Li, Matthew C. Troutman et al. · Journal of Virology · 2017 · 86 citations · Full text

Qualitative and quantitative evaluation of <scp>S</scp>imon™, a new <scp>CE</scp>‐based automated Western blot system as applied to vaccine development

Richard R. Rustandi, John W. Loughney, Melissa Hamm et al. · Electrophoresis · 2012 · 59 citations

Residual bovine serum albumin (BSA) quantitation in vaccines using automated Capillary Western technology

John W. Loughney, Catherine Lancaster, Sha Ha et al. · Analytical Biochemistry · 2014 · 58 citations

Vaccination, Vaccine Development, Medicine +7

Development of a microchip capillary electrophoresis method for determination of the purity and integrity of mRNA in lipid nanoparticle vaccines

Jessica Raffaele, John W. Loughney, Richard R. Rustandi · Electrophoresis · 2021 · 47 citations · Full text

Engineering, Immunology, Lipid Nanoparticles +16